Related Experiment Video
Updated: Jan 12, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Inhibition the MAP3K20-mediated ribotoxic stress response pathway downregulates M1 macrophage polarization in
Wan-Yu Xia1, Xin-Yuan Ma2, Zi-Meng Zhu1
1Acupuncture and Moxibustion School, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Abstract:
To comprehensively investigate driven ribotoxic stress response (RSR) activation of M1 macrophage polarization in ulcerative colitis (UC), Gene Set Variation Analysis (GSVA) of intestinal tissues, weighted gene co-expression network analysis (WGCNA) based identification of RSR hub genes correlated with immune infiltration, and single-cell RNA sequencing were used. The multi-modal approach identified six core RSR hub genes (SNAL1, MDM2, MAPK11, MAP3K20, E2F1, BMP6) and established MAP3K20 as the pivotal kinase coordinating RSR-mediated M1 macrophage polarization in UC pathogenesis. Using DSS-induced UC models, we collectively demonstrated that MAP3K20 concurrent regulation of JNK/p38 signaling drive M1 macrophage polarization and UC inflammation, while pharmacological inhibition with Vemurafenib (MAP3K20 inhibitor) effectively attenuated both pathway activation and pathological damage. Our study provides a potential novel therapeutic target and clue for treating UC.
Insights
This study reveals how ribotoxic stress response (RSR) drives M1 macrophage polarization in ulcerative colitis (UC). Targeting MAP3K20 kinase with Vemurafenib shows promise for treating UC by reducing inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Ulcerative colitis (UC) involves complex immune dysregulation.
- M1 macrophage polarization contributes to UC pathogenesis.
- Ribotoxic stress response (RSR) role in UC is not fully understood.
Purpose of the Study:
- Investigate RSR activation of M1 macrophage polarization in UC.
- Identify key genes and pathways involved in RSR-mediated M1 polarization in UC.
- Evaluate MAP3K20 as a therapeutic target for UC.
Main Methods:
- Gene Set Variation Analysis (GSVA) of intestinal tissues.
- Weighted gene co-expression network analysis (WGCNA) for RSR hub genes.
- Single-cell RNA sequencing.
- Dextran Sodium Sulfate (DSS)-induced UC models.
Main Results:
- Identified six core RSR hub genes (SNAL1, MDM2, MAPK11, MAP3K20, E2F1, BMP6).
- Established MAP3K20 as the pivotal kinase in RSR-mediated M1 macrophage polarization in UC.
- MAP3K20 regulates JNK/p38 signaling, driving M1 polarization and UC inflammation.
- Vemurafenib (MAP3K20 inhibitor) attenuated inflammation and pathological damage in UC models.
Conclusions:
- MAP3K20 is a key mediator of RSR-driven M1 macrophage polarization in UC.
- Targeting MAP3K20 offers a potential therapeutic strategy for ulcerative colitis.
- This research provides novel insights into UC pathogenesis and treatment.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

